MeSH term
Frequency | Condition_Probility | Humans | 373 | 0.0 |
Software | 2 | 0.0 |
Animals | 94 | 0.0 |
Forecasting | 2 | 0.0 |
Lung/*anatomy & histology | 2 | 66.0 |
Magnetic Resonance Imaging/*methods | 7 | 10.0 |
Research Support, Non-U.S. Gov't | 168 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 99 | 0.0 |
Adolescent | 16 | 0.0 |
Adult | 55 | 0.0 |
Aged | 21 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
Aging/*physiology | 2 | 0.0 |
Ascorbic Acid/pharmacology | 5 | 9.0 |
Child | 13 | 0.0 |
Child, Preschool | 7 | 0.0 |
Comparative Study | 37 | 0.0 |
Electron Spin Resonance Spectroscopy | 183 | 69.0 |
Hydrogen Peroxide/metabolism | 3 | 2.0 |
Infant | 4 | 0.0 |
Light | 3 | 1.0 |
Lipid Peroxidation | 7 | 6.0 |
Lipofuscin/metabolism/*radiation effects | 2 | 100.0 |
Middle Aged | 41 | 0.0 |
Oxygen Consumption | 3 | 1.0 |
Reactive Oxygen Species/metabolism | 4 | 1.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Cyclic N-Oxides | 30 | 93.0 |
Dose-Response Relationship, Drug | 16 | 0.0 |
Electron Spin Resonance Spectroscopy/*methods | 6 | 85.0 |
Erythrocytes/*metabolism | 11 | 5.0 |
Models, Chemical | 4 | 1.0 |
Ozone/*pharmacology | 2 | 28.0 |
Spin Labels | 98 | 79.0 |
Temperature | 28 | 2.0 |
Thermodynamics | 13 | 3.0 |
DNA Damage | 2 | 0.0 |
*Oxidative Stress | 2 | 0.0 |
English Abstract | 43 | 0.0 |
Erythrocyte Membrane/*metabolism | 10 | 14.0 |
Cattle | 14 | 0.0 |
Magnetics | 2 | 2.0 |
Models, Theoretical | 9 | 7.0 |
Time Factors | 18 | 0.0 |
Artifacts | 4 | 7.0 |
*Computer Simulation | 2 | 2.0 |
Amino Acid Sequence | 12 | 0.0 |
Cell Cycle Proteins/*genetics | 2 | 1.0 |
Molecular Sequence Data | 10 | 0.0 |
Phosphoproteins/*genetics | 3 | 1.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Female | 54 | 0.0 |
Free Radicals | 35 | 23.0 |
Male | 69 | 0.0 |
Myocardium/*metabolism | 2 | 0.0 |
Alleles | 2 | 0.0 |
Heterozygote | 3 | 0.0 |
Mice | 13 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Reference Values | 5 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Copper/pharmacology | 3 | 5.0 |
DNA Damage/*drug effects | 3 | 6.0 |
Free Radical Scavengers/pharmacology | 2 | 3.0 |
Genes, ras/genetics | 2 | 1.0 |
Hydrogen Peroxide/*metabolism | 3 | 7.0 |
Mass Fragmentography | 2 | 0.0 |
NAD/metabolism | 2 | 3.0 |
Nitric Oxide/*metabolism | 2 | 1.0 |
Chromatography, Gel | 2 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 7 | 0.0 |
Indicators and Reagents | 2 | 0.0 |
Rheology | 2 | 2.0 |
Scattering, Radiation | 3 | 2.0 |
Spectrometry, Fluorescence | 8 | 1.0 |
Models, Biological | 8 | 0.0 |
Oxidative Stress | 8 | 2.0 |
Algorithms | 7 | 1.0 |
Flow Cytometry | 2 | 0.0 |
Fluorescent Dyes | 3 | 0.0 |
Micelles | 2 | 4.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
*Ultrasonics | 2 | 12.0 |
Biophysics | 4 | 9.0 |
*Electron Spin Resonance Spectroscopy | 14 | 82.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Oxidation-Reduction | 27 | 2.0 |
Rats | 19 | 0.0 |
Hydroxyl Radical/metabolism | 3 | 15.0 |
DNA, Complementary | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Sex Factors | 2 | 0.0 |
Electron Spin Resonance Spectroscopy/methods | 15 | 68.0 |
In Vitro | 37 | 0.0 |
Spin Trapping | 8 | 80.0 |
Superoxides/*antagonists & inhibitors | 2 | 100.0 |
Cyclic N-Oxides/*chemistry | 3 | 100.0 |
Drug Stability | 3 | 1.0 |
Neutrophils/drug effects/*metabolism | 5 | 7.0 |
Tetradecanoylphorbol Acetate/pharmacology | 5 | 0.0 |
Zymosan/pharmacology | 4 | 4.0 |
*Cyclic N-Oxides | 3 | 100.0 |
Molecular Structure | 3 | 0.0 |
*Spin Labels | 29 | 90.0 |
*Spin Trapping | 2 | 100.0 |
United States | 2 | 0.0 |
Proteins/*chemistry | 4 | 4.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Liposomes | 6 | 2.0 |
Mice, Inbred HRS | 2 | 18.0 |
Disease Models, Animal | 5 | 0.0 |
Iron/metabolism | 4 | 3.0 |
Rats, Wistar | 2 | 0.0 |
Reactive Oxygen Species/*metabolism | 5 | 3.0 |
Recombinant Proteins | 2 | 0.0 |
Phagocytosis | 2 | 0.0 |
Binding Sites | 16 | 0.0 |
Ferritin/*metabolism | 2 | 7.0 |
Horses | 3 | 2.0 |
Hydrogen-Ion Concentration | 16 | 1.0 |
Sheep | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Kinetics | 38 | 0.0 |
Ligands | 8 | 0.0 |
Magnetic Resonance Spectroscopy | 11 | 2.0 |
Models, Molecular | 6 | 0.0 |
Protein Conformation | 26 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 27 | 0.0 |
Centrifugation | 2 | 2.0 |
Crystallization | 5 | 2.0 |
Hydrogen Bonding | 4 | 2.0 |
Protein Structure, Secondary | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Diffusion | 3 | 3.0 |
Nitrogen Oxides/chemistry | 2 | 66.0 |
Guinea Pigs | 2 | 0.0 |
Cell Membrane/*chemistry | 2 | 6.0 |
Azides/metabolism | 2 | 33.0 |
Copper/metabolism | 2 | 3.0 |
Cyclic N-Oxides/metabolism | 8 | 72.0 |
Ethanol/metabolism | 2 | 9.0 |
Formic Acids/metabolism | 2 | 50.0 |
Hydroxyl Radical/*metabolism | 2 | 22.0 |
Peroxidase/metabolism | 3 | 2.0 |
Superoxide Dismutase/*metabolism | 2 | 5.0 |
Blood Platelets/*drug effects/metabolism/physiology/ultrastructure | 2 | 100.0 |
Cell Membrane/drug effects/metabolism/physiology | 2 | 100.0 |
Cells, Cultured | 8 | 0.0 |
Detergents | 2 | 1.0 |
Lipid Bilayers/blood | 4 | 100.0 |
Octoxynol | 2 | 3.0 |
Sodium Selenite/*pharmacology | 2 | 40.0 |
Swine | 5 | 0.0 |
Coronary Vessels/*anatomy & histology | 2 | 100.0 |
*Magnetic Resonance Imaging | 12 | 7.0 |
Myocardium/metabolism | 2 | 0.0 |
Oxygen/*blood | 3 | 6.0 |
*Heat | 4 | 3.0 |
Lasers | 2 | 1.0 |
Stress, Mechanical | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Sequence Analysis | 2 | 0.0 |
Nitrogen Isotopes | 3 | 8.0 |
Copper/*metabolism | 3 | 3.0 |
Computer Simulation | 2 | 0.0 |
*Membrane Fluidity | 15 | 65.0 |
Prognosis | 2 | 0.0 |
Mathematics | 10 | 5.0 |
Nuclear Magnetic Resonance, Biomolecular/*methods | 2 | 20.0 |
*Protein Conformation | 3 | 1.0 |
Magnetic Resonance Imaging/*instrumentation | 2 | 22.0 |
Phantoms, Imaging | 4 | 18.0 |
*Xenon Isotopes | 2 | 100.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Magnetic Resonance Imaging/methods | 2 | 2.0 |
Oxygen/blood | 4 | 3.0 |
Sensitivity and Specificity | 5 | 0.0 |
Free Radicals/metabolism | 5 | 9.0 |
Calorimetry, Differential Scanning | 3 | 9.0 |
Free Radicals/analysis | 2 | 40.0 |
Magnetic Resonance Spectroscopy/*methods | 6 | 25.0 |
Oxidative Stress/*physiology | 2 | 2.0 |
Spectrometry, Fluorescence/methods | 2 | 7.0 |
Biotransformation | 2 | 0.0 |
Spectrophotometry, Ultraviolet | 4 | 2.0 |
Superoxide Dismutase/pharmacology | 4 | 10.0 |
Protons | 3 | 3.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Cholesterol/blood | 10 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Species Specificity | 7 | 0.0 |
Triglycerides/blood | 6 | 0.0 |
Brain/*metabolism | 2 | 0.0 |
Brain Chemistry | 3 | 1.0 |
Magnetic Resonance Spectroscopy/*diagnostic use/methods | 2 | 50.0 |
Signal Processing, Computer-Assisted | 3 | 6.0 |
Brain/*anatomy & histology | 2 | 28.0 |
Amidines/pharmacology | 2 | 15.0 |
Rabbits | 4 | 0.0 |
Vitamin E/pharmacology | 3 | 9.0 |
Singlet Oxygen | 2 | 28.0 |
Hela Cells | 4 | 0.0 |
Cell Line | 4 | 0.0 |
Molecular Conformation | 9 | 3.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Dogs | 5 | 0.0 |
Lipoproteins, LDL/metabolism | 2 | 0.0 |
*Myocardial Reperfusion | 2 | 40.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Permeability | 3 | 1.0 |
Erythrocyte Membrane/*drug effects | 7 | 63.0 |
Erythrocyte Membrane/chemistry/*drug effects | 3 | 100.0 |
Membrane Fluidity/drug effects | 5 | 26.0 |
Membrane Proteins/chemistry | 2 | 4.0 |
*Membranes, Artificial | 3 | 3.0 |
Mice, Inbred BALB C | 2 | 0.0 |
*Glycoproteins | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Lipids/blood | 4 | 0.0 |
NADPH Oxidase/metabolism | 2 | 4.0 |
Superoxides/*metabolism | 6 | 6.0 |
Aging/*metabolism | 2 | 0.0 |
Membrane Fluidity | 12 | 34.0 |
Membrane Lipids/metabolism | 3 | 6.0 |
Heme/chemistry | 2 | 9.0 |
Structure-Activity Relationship | 9 | 0.0 |
*Free Radicals | 3 | 42.0 |
Erythrocytes/metabolism | 4 | 2.0 |
Magnetic Resonance Spectroscopy/methods | 3 | 6.0 |
*Death | 3 | 60.0 |
Helium | 2 | 40.0 |
Isotopes | 2 | 40.0 |
Calcium/*pharmacology | 4 | 4.0 |
Cell Membrane/metabolism | 2 | 0.0 |
*Lipid Bilayers | 5 | 29.0 |
Neutrophils/*metabolism | 7 | 3.0 |
Cytopathogenic Effect, Viral | 2 | 1.0 |
Evaluation Studies | 2 | 0.0 |
Reactive Oxygen Species | 2 | 1.0 |
*Magnetic Resonance Spectroscopy | 9 | 18.0 |
Ethanol/*pharmacology | 3 | 2.0 |
Phospholipids/*analysis | 2 | 13.0 |
Oxygen/metabolism | 5 | 2.0 |
Solubility | 3 | 0.0 |
Superoxides/metabolism | 4 | 1.0 |
Antioxidants/*pharmacology | 3 | 2.0 |
Solutions | 3 | 1.0 |
Stearic Acids/chemistry | 2 | 66.0 |
Femoral Artery/physiology | 2 | 66.0 |
Electricity | 3 | 23.0 |
Lipoproteins, LDL/blood/*chemistry | 2 | 25.0 |
Protein Binding | 18 | 0.0 |
Ultracentrifugation | 3 | 1.0 |
Mutagenicity Tests | 2 | 1.0 |
Freeze Fracturing | 3 | 13.0 |
Microscopy, Electron | 4 | 0.0 |
Gerbillinae | 2 | 5.0 |
Lipids/*metabolism | 3 | 1.0 |
Membrane Proteins/*metabolism | 4 | 0.0 |
Benzenesulfonates/*diagnostic use | 2 | 100.0 |
Nitroso Compounds/*diagnostic use | 2 | 100.0 |
Neutrophils/metabolism | 2 | 1.0 |
Xanthine Oxidase/metabolism | 3 | 15.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Spectrophotometry | 7 | 4.0 |
Diabetes Mellitus, Type 1/*blood | 3 | 2.0 |
Lipids/*blood | 3 | 0.0 |
Erythrocyte Membrane/*physiology | 8 | 61.0 |
*Brain Chemistry | 3 | 1.0 |
Lipid Bilayers | 4 | 9.0 |
Membrane Lipids/blood | 8 | 57.0 |
Models, Structural | 3 | 1.0 |
Reproducibility of Results | 3 | 0.0 |
Lipoproteins, LDL/*blood | 3 | 1.0 |
Nitrogen Oxides | 4 | 80.0 |
*Free Radical Scavengers | 4 | 30.0 |
Membrane Fluidity/*physiology | 2 | 40.0 |
Phospholipids/blood | 7 | 5.0 |
Nitric Oxide/*chemistry | 2 | 66.0 |
Oxygen/*metabolism | 8 | 6.0 |
Cell Survival | 2 | 0.0 |
Membrane Proteins/*chemistry | 2 | 4.0 |
*DNA Damage | 2 | 0.0 |
Oxygen Consumption/drug effects | 4 | 10.0 |
*Contrast Media | 2 | 7.0 |
Biological Transport | 2 | 0.0 |
Membrane Lipids/*blood | 2 | 20.0 |
Osmolar Concentration | 6 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Superoxide Dismutase/*pharmacology | 2 | 25.0 |
Insulin/*pharmacology | 2 | 0.0 |
Calcimycin/pharmacology | 3 | 1.0 |
Calcium/pharmacology | 3 | 1.0 |
Erythrocytes/drug effects/metabolism | 2 | 14.0 |
Membrane Fluidity/drug effects/*physiology | 2 | 100.0 |
Rats, Inbred SHR | 2 | 2.0 |
Rats, Inbred WKY | 2 | 2.0 |
Ultraviolet Rays | 3 | 0.0 |
Leukocytes/enzymology | 2 | 1.0 |
Protein Denaturation | 3 | 1.0 |
Spectrum Analysis, Raman | 2 | 10.0 |
Membrane Lipids/*metabolism | 3 | 9.0 |
Photochemistry | 2 | 3.0 |
Image Enhancement/methods | 2 | 22.0 |
Hemoglobins/*metabolism | 3 | 7.0 |
Liver/pathology | 2 | 1.0 |
Antigens, Viral/analysis | 2 | 2.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
*Immediate-Early Proteins | 2 | 0.0 |
Cholesterol/*blood | 3 | 1.0 |
Coronary Disease/blood | 2 | 7.0 |
Lipoproteins/*blood | 7 | 1.0 |
Lipoproteins, LDL/blood | 4 | 1.0 |
Fasting | 2 | 0.0 |
Lipoproteins, HDL Cholesterol/blood | 2 | 0.0 |
Lipoproteins, LDL Cholesterol/blood | 2 | 0.0 |
Chemistry, Physical | 6 | 4.0 |
Macromolecular Substances | 7 | 0.0 |
Hydroxides/*metabolism | 3 | 75.0 |
Hydroxyl Radical | 5 | 16.0 |
Spectrum Analysis | 4 | 7.0 |
*Oxygen Consumption | 3 | 7.0 |
Membrane Proteins/analysis | 3 | 2.0 |
Antigens, Viral/*analysis | 2 | 4.0 |
Erythrocytes/*physiology | 4 | 9.0 |
Chemistry | 7 | 3.0 |
Mutation | 4 | 0.0 |
Rats, Inbred Strains | 2 | 0.0 |
Cyclic N-Oxides/pharmacology | 2 | 22.0 |
Image Processing, Computer-Assisted/*methods | 2 | 8.0 |
Cell Membrane/drug effects | 2 | 5.0 |
Fluorescence Polarization | 2 | 3.0 |
Lipid Peroxidation/drug effects | 2 | 3.0 |
Membrane Fluidity/*drug effects | 9 | 90.0 |
Antioxidants/*metabolism | 2 | 2.0 |
Blood Proteins/*analysis | 2 | 1.0 |
Peroxidase/*blood | 2 | 4.0 |
*Erythrocytes/metabolism | 2 | 100.0 |
Hemoglobins | 3 | 10.0 |
Lipoproteins, LDL/*blood/isolation & purification | 2 | 16.0 |
Methods | 3 | 1.0 |
Membrane Lipids/analysis | 5 | 33.0 |
Calcium/blood | 2 | 0.0 |
Concanavalin A/pharmacology | 2 | 0.0 |
Coronary Disease/*blood | 4 | 6.0 |
Infant, Newborn | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Water | 2 | 3.0 |
Erythrocytes/drug effects/*metabolism | 2 | 10.0 |
Erythrocyte Membrane/*physiopathology | 2 | 100.0 |
Hypertension/*blood | 2 | 3.0 |
Palmitic Acids | 2 | 100.0 |
Membrane Lipids/*physiology | 2 | 16.0 |
Simplexvirus/immunology/*isolation & purification | 2 | 66.0 |
*Lipid Peroxidation | 2 | 4.0 |
Lipoproteins, HDL/blood | 4 | 1.0 |
Cyclic N-Oxides/diagnostic use | 3 | 75.0 |
Erythrocyte Membrane/drug effects | 2 | 22.0 |
Amino Acids/analysis | 2 | 0.0 |
Apolipoproteins/blood | 2 | 0.0 |
Chickens | 3 | 0.0 |
Erythrocyte Membrane/*analysis | 10 | 47.0 |
*Membrane Proteins | 3 | 0.0 |
Spherocytosis, Hereditary/*blood | 2 | 40.0 |
Spin Labels/metabolism | 2 | 100.0 |
Viscosity | 2 | 6.0 |
Centrifugation, Density Gradient | 2 | 0.0 |
Hydroxides | 2 | 40.0 |
*Erythrocyte Aging | 2 | 9.0 |
Fatty Acids/analysis | 4 | 13.0 |
Membrane Lipids/*analysis | 3 | 25.0 |
Magnetic Resonance Spectroscopy/*diagnostic use | 3 | 18.0 |
Electrochemistry | 2 | 2.0 |
Lipoproteins, HDL/*blood | 2 | 1.0 |
Heme | 2 | 50.0 |
*Isothiocyanates | 2 | 66.0 |
Thiocyanates | 2 | 8.0 |
Membrane Potentials | 3 | 1.0 |
Neuraminidase | 2 | 5.0 |
Serum Albumin/*metabolism | 2 | 4.0 |
Sialic Acids/blood | 2 | 15.0 |
Glycoproteins/*blood | 2 | 2.0 |
Membrane Proteins/*blood | 5 | 9.0 |
Sulfhydryl Compounds/analysis | 2 | 10.0 |
Lipoproteins, VLDL/blood | 2 | 0.0 |
Hemolysis | 6 | 1.0 |
Cold | 2 | 1.0 |
Erythrocyte Membrane/*physiology/ultrastructure | 2 | 40.0 |
Spectrin/*metabolism | 3 | 50.0 |
Platelet Aggregation/drug effects | 2 | 0.0 |
Protein Conformation/drug effects | 2 | 3.0 |
Lipid Peroxides/blood | 3 | 12.0 |
Erythrocyte Membrane/*ultrastructure | 3 | 42.0 |
Chlorpromazine/*pharmacology | 2 | 9.0 |
Membrane Lipids | 2 | 33.0 |
Membrane Proteins | 2 | 5.0 |
Maleimides | 3 | 33.0 |
Sodium Chloride | 2 | 7.0 |
Myelin Basic Proteins/*metabolism | 2 | 4.0 |
Motion | 2 | 10.0 |
Erythrocyte Membrane/metabolism/*ultrastructure | 2 | 66.0 |
*Serum Albumin | 2 | 33.0 |
Cholesterol/analysis | 5 | 10.0 |
Erythrocytes/*drug effects | 2 | 9.0 |
Phospholipids/analysis | 4 | 11.0 |
Spectrin/analysis | 2 | 50.0 |
*Renal Dialysis | 2 | 0.0 |
*Erythrocyte Membrane | 2 | 50.0 |
Spin Labels/*metabolism | 2 | 66.0 |
*Hemeproteins | 2 | 66.0 |
Methemoglobin | 3 | 60.0 |
Cell Membrane/*drug effects | 2 | 25.0 |
*Temperature | 2 | 6.0 |
Heat | 2 | 0.0 |
Circular Dichroism | 3 | 0.0 |
*Hemoglobin A | 2 | 50.0 |
*Methemoglobin | 3 | 50.0 |
Phytic Acid | 2 | 100.0 |
Erythrocytes/*analysis | 5 | 12.0 |
*Hemoglobins | 4 | 44.0 |
*Erythrocytes | 2 | 11.0 |
Copper/chemistry | 2 | 10.0 |
Erythrocyte Membrane/drug effects/*metabolism | 2 | 18.0 |
Membrane Proteins/blood | 2 | 5.0 |
Stearic Acids | 3 | 100.0 |
Magnesium/pharmacology | 2 | 1.0 |
Osmotic Fragility | 2 | 16.0 |
Egtazic Acid/pharmacology | 2 | 1.0 |
Brain/*physiology | 2 | 1.0 |
Lipids/metabolism | 3 | 0.0 |
Microwaves | 2 | 8.0 |
*Serum Albumin, Bovine | 2 | 66.0 |
Erythrocytes/*ultrastructure | 2 | 22.0 |
Azides | 3 | 27.0 |
Cyanides | 5 | 71.0 |
Imidazoles | 2 | 16.0 |
Phosphatidylcholines | 3 | 8.0 |
Fluorides | 2 | 16.0 |
Oxyhemoglobins | 2 | 33.0 |
Phosphatidylethanolamines | 2 | 11.0 |
Phosphatidylglycerols | 2 | 66.0 |
Phosphatidylserines | 2 | 20.0 |
Erythrocytes/drug effects/*ultrastructure | 2 | 40.0 |
Pliability | 2 | 9.0 |
